Coagulation Factor V Leiden Mutation May Have a Racial Background

Thromb Haemost 1995; 74(05): 1381-1382
DOI: 10.1055/s-0038-1649946

Letter To The Editor

Schattauer GmbH Stuttgart

Hironobu Fujimura

The Department of Surgery II, Osaka University Medical School, Suita, Osaka, Japan

,

Jun-ichi Kambayashi

The Department of Surgery II, Osaka University Medical School, Suita, Osaka, Japan

,

Morito Monden

The Department of Surgery II, Osaka University Medical School, Suita, Osaka, Japan

,

Hisao Kato

¹The National Cardiovascular Center Research Institute, Suita, Osaka, Japan

,

Toshiyuki Miyata

¹The National Cardiovascular Center Research Institute, Suita, Osaka, Japan

References
1 Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-1506
2 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
3 Bertina RM, Koeleman BP C, Koster T, Rosendaal FR, Dirven RJ, Ronde H, Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67
4 Dahlbäck B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994; 91: 1396-1400
5 Beauchamp NJ, Daly ME, Hampton KK, Cooper PC, Preston FE, Peale IR. High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol 1994; 88: 219-222
6 Aoki N, Tateno K, Sakata Y. Differences of frequency distributions of plasminogen phenotypes between Japanese and American populations: new methods for the detection of plasminogen variants. Biochem Genet 1984; 22: 871-881